S.L.A. Pharma AG

ACTIVE

Switzerlandwww.slapharma.comPrivate11–50 employeesEstablished: 1997-01-01

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1997

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

45.5%

Phase 3

45.5%

Phase 1

9.1%

Trial Status Distribution

Active, not recruiting

9.1%

Completed

63.6%

Unknown

18.2%

Withdrawn

9.1%

Clinical Trials

Trials sponsored by this organization (11)

Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease

Phase 1

Completed

interventional

Oct 200719 participants

A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

Phase 2

Completed

interventional

Nov 200658 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations

S.L.A. Pharma AG

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (11)

Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds

EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)

Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

Diltiazem Hydrochloride Cream for Anal Fissure

Naloxone SR Capsules in Patients With Opioid Induced Constipation

Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease

A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

Approvals

News